Dupilumab in the Treatment of Dyshidrosis: A Report of Two Cases of Dyshidrotic Eczema
[vc_row][vc_column][vc_column_text]Dyshidrotic eczema (dyshidrosis) primarily appears on the palms and soles and is often difficult to treat. In this Journal of Drugs in Dermatology (JDD) case report, we look at two successfully treated unique cases of recalcitrant dyshidrotic eczema (dyshidrosis). This article was written by Gillian K. Weston MD, Jette Hooper, Bruce E. Strober MD PhD and publish …
Diagnosing Alopecias: Key Elements and Insights from Clinical Cases
AlopeciaHair loss is a common yet complex condition that presents a significant challenge for both patients and dermatologists alike. Accurate diagnosis and effective management often require a meticulous and nuanced approach that enables the physician to discern subtle clues that distinguish between various etiologic forms of alopecia. At the 2025 Orlando Dermatology, Aesthetic, and Surgical Conference, …
Alopecia
Case Series of Acral and Mucosal Melanoma in a Diverse Patient Population
acral melanomaINTRODUCTION Melanoma accounts for only 1% of all skin cancers but is responsible for most skin cancer-related deaths.1 Acral and mucosal melanoma (AMM) accounts for only 4% of all new melanomas but is associated with poorer prognosis.2 Patients of color are disproportionately affected by AMM. Elucidating the clinical, genetic, and environmental features of AMM can guide advancements in the …
acral melanoma
A Massive Case of Cutaneous Diffuse Large B-Cell Lymphoma
B-Cell LymphomaABSTRACT Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, and extranodal involvement is seen in approximately 40% of cases. However, cases involving the skin and muscle are rare, and skin manifestations most commonly present as plaques, papules, small nodules, or ulcers. In this report, JDD authors Lauren E. Merz MD MSc, Christopher B. Hergott MD PhD, and Reb …
B-Cell Lymphoma
A Case of Late-Onset Alopecia Areata
ALOPECIA AREATAINTRODUCTION Alopecia areata (AA) is a condition characterized by nonscarring hair loss. Cases of alopecia areata are most commonly seen in patients under age 30 and are frequently idiopathic. In this report, we discuss a woman in her 50s who developed AA shortly after receiving the Tdap vaccine and after one year of guselkumab therapy.   CASE A woman in her 50s with history of psor …
ALOPECIA AREATA
error

Enjoy this blog? Please spread the word :)